Эмили Остер - Спокойная и уверенная

Mountain Dew — безалкогольный сильногазированный прохладительный напиток, торговая марка американской компании PepsiCo. Прим. перев.

B. H. Bech et al., “Coffee and Fetal Death: Study with Prospective Data,” American Journal of Epidemiology 2005): 983–90.

X. Weng, R. Odouli, and D. Li, “Maternal Consumption during Pregnancy and the Risk of Miscarriage: Prospective Cohort Study,” American Journal of Obstetrics and 198: 279. e1–279. e8.

J. D. Peck, A. Leviton, and L. D. Review of the Epidemiologic Evidence Concerning the Reproductive Health Effects of Caffeine Consumption: A 2000–2009 Update,” and Chemical Toxicology 48, no. 10 (2010): 2549–76.

Weng, Odouli, and Li fi “Coffee and Fetal Death: A Cohort Study Prospective Data”.

L. Fenster et al., Caffeinated Beverages, Decaffeinated Coffee and Spontaneous Abortion,” Epidemiology 8, no. 5 (September 1997): 515–23.

B. H. Bech of Reducing Caffeine Intake on Birth Weight and Length Randomized Controlled Trial,” BMJ 334, no. 7590 (February 2007): 409.

J. L. Moderate Caffeine Use and the Risk of Spontaneous Abortion Intrauterine Growth Retardation,” JAMA 269, no. 5 (February 3, 1993): 593–97.

B. H. Bech et al., “Coffee and Fetal Death: A Cohort Study with Prospective”, American Journal of Epidemiology 162 (2005): 983–90.

S. Cnattingius et al., “Caffeine Intake and the Risk of First-Trimester Spontaneous Abortion,” New England Journal of Medicine 343, no. 25 (December 2000): 1839–45.

M. H. Aliyu et al., “Association between Tobacco Use in Pregnancy and Placenta-Associated Syndromes: A Population-Based Study,” Archives of Gynecology and Obstetrics 283, no. 4 (April 2011): 729–34.

V. W. Jaddoe et al., “Active and Passive Maternal Smoking during Pregnancy and the Risks of Low Birthweight and Preterm Birth: The Generation R Study,” Paediatric and Perinatal Epidemiology 22, no. 2 (March 2008): 162–71.

P. Fleming and P. S. Blair, “Sudden Infant Death Syndrome and Parental Smoking,” Early Human Development 83, no. 11 (November 2007): 721–25.

G. Salmasi et al., Knowledge Synthesis Group, “Environmental Tobacco Smoke Exposure and Perinatal Outcomes: A Systematic Review and Meta-Analyses,” Acta Obstetricia et Gynecologia Scandinavica 89, no. 4 (2010): 423–41.

Aliyu et al., “Association between Tobacco Use in Pregnancy and Placenta-Associated Syndromes.”

J. Lumley et al., “Interventions Promoting Smoking Cessation Pregnancy” (Review), Cochrane Database of Systematic article no. CD001055 (October 18, 2004).

J. Lumley et al., “Interventions Promoting Smoking Cessation Pregnancy” (Review), Cochrane Database of Systematic article no. CD001055 (October 18, 2004).

T. Coleman, C. Chamberlain, and J. Leonardi-Bee, “Efficacy and Safety of Nicotine Replacement Therapy Smoking Cessation in Pregnancy: Systematic Review and Meta-Analysis,” 106, no. 1 (January 2011): 52–61.

C. Oncken et al., “Nicotine Gum Smokers: A Randomized Controlled Trial,” Obstetrics & Gynecology no. 4 (October 2008): 859–67.

S. Tong et al., “Miscarriage Risk Asymptomatic Women after a Normal First-Trimester Prenatal Obstetrics & Gynecology 111, no. 3 (2008): 710–14; G. Makrydimas Fetal Loss Following Ultrasound Diagnosis of a Live Fetus at Weeks of Gestation,” Ultrasound in Obstetrics & Gynecology 22, 2003): 368–72; J. L. Mills et al., “Incidence of Spontaneous Abortion Normal Women and Insulin-Dependent Diabetic Women Pregnancies Were Identifi ed Within 21 Days of Conception,” New Journal of Medicine 319, no. 25 (1988): 1617–23.

L. Regan, Braude, and P. L. Trembath, “Influence of Past Reproductive Risk of Spontaneous Abortion,” BMJ 299, no. 6698 (1989): 541–5.

G. Makrydimas et al., “Fetal Loss Following Ultrasound Diagnosis of a Live 6–10 Weeks of Gestation.”

Y. Ezra and J. G. Schenker, “Abortion Rate in Assisted Reproduction-True Increase?” Early Pregnancy: Biology and Medicine 1, no. 3 (1995): 171–75.

L. M. Hill et al., “Fetal Loss Rate After Ultrasonically Documented Cardiac Activity Between 6 and 14 Weeks, Menstrual Age,” Journal of Clinical Ultrasound 19, no. 4 (1991): 221–23.

Steven Gabbe, Jennifer Niebyl, and Joe Leigh Simpson, Obstetrics: Normal and Problem Pregnancies (Philadelphia, PA: Churchill Livingstone, 2007); Y. Sorokin et al., “Postmortem Chorionic Villus Sampling: Correlation of Cytogenetic and Ultrasound Findings,” American Journal of Medical Genetics 39, no. 3 (1991): 314–16.

J. L. Mills et al., “Incidence of Spontaneous Abortion Among Normal Women and Insulin-Dependent Diabetic Women Whose Pregnancies Were Identified Within 21 Days of Conception,” New England Journal Medicine 319, no. 25 (1988): 1617–23; D. H. Gilmore and M. “Spontaneous Fetal Loss Rate in Early Pregnancy,” Lancet (1985): 107.

P. R. Wyat et al., “Age-Specific Risk of Fetal Loss Observed Second Trimester Serum Screening Population,” American Journal Obstetrics & Gynecology 192, no. 1 (2005): 240–46.

Гермафоб — человек, панически боящийся микробов. Прим. перев.

Кампилобактер — бактерия, вызывающая кампилобактериоз — острую кишечную инфекцию. Прим. ред.

Токсоплазмоз — паразитарное заболевание человека и животных, вызываемое токсоплазмами . Прим. ред.

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm.

A. J. C. Cook et al., “Sources of Toxoplasma Infection in Pregnant Women: European Multicentre Case-Control Study,” BMJ 321, no. 7254 (2000): 142–47.

http://www.cdc.gov/mmwr/preview/rr4902a5.htm.

Исследование на наличие иммунитета к токсоплазме входит в перечень обязательных обследований в первом и третьем триместрах беременности в Российской Федерации. Прим. науч. ред.

V. Janakiraman, “Listeriosis in Pregnancy: Diagnosis, Treatment and Prevention,” Review of Obstetrics Gynecology 1, no. 4 (Fall 2008): 179–85.